APA (7th ed.) Citation

Bohm, K., Filomena, A., Schneiderhan-Marra, N., Krause, G., & Sievers, C. (2017). Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine, 35(43), 5883-5889. https://doi.org/10.1016/j.vaccine.2017.08.089

Chicago Style (17th ed.) Citation

Bohm, Katrin, Angela Filomena, Nicole Schneiderhan-Marra, Gérard Krause, and Claudia Sievers. "Validation of HAV Biomarker 2A for Differential Diagnostic of Hepatitis A Infected and Vaccinated Individuals Using Multiplex Serology." Vaccine 35, no. 43 (2017): 5883-5889. https://doi.org/10.1016/j.vaccine.2017.08.089.

MLA (9th ed.) Citation

Bohm, Katrin, et al. "Validation of HAV Biomarker 2A for Differential Diagnostic of Hepatitis A Infected and Vaccinated Individuals Using Multiplex Serology." Vaccine, vol. 35, no. 43, 2017, pp. 5883-5889, https://doi.org/10.1016/j.vaccine.2017.08.089.